Literature DB >> 16493204

Age at onset of multiple sclerosis may be influenced by place of residence during childhood rather than ancestry.

J Kennedy1, P O'Connor, A D Sadovnick, M Perara, I Yee, B Banwell.   

Abstract

Multiple sclerosis (MS) most commonly affects individuals of Northern European descent who live in countries at high latitude. The relative contributions of ancestry, country of birth and residence as determinants of MS risk have been studied in adult MS, but have not been explored in the pediatric MS population. In this study, we compare the demographics of pediatric- and adult-onset MS patients cared for in Toronto, Ontario, Canada, a multicultural region. The country of birth, residence during childhood, and ancestry were compared for 44 children and 573 adults. Our results demonstrate that although both the pediatric and adult cohorts were essentially born and raised in the same region of Ontario, Canada, children with MS were more likely to report Caribbean, Asian or Middle Eastern ancestry, and were less likely to have European heritage compared with individuals with adult-onset MS. The difference in ancestry between the pediatric and adult MS cohorts can be explained by two hypotheses: (1) individuals raised in a region of high MS prevalence, but whose ancestors originate from regions in which MS is rare, have an earlier age of MS onset, and (2) the place of residence during childhood, irrespective of ancestry, determines lifetime MS risk -- a fact that will be reflected in a change in the demographics of the adult MS cohort in our region as Canadian-raised children of recent immigrants reach the typical age of adult-onset MS.

Entities:  

Mesh:

Year:  2006        PMID: 16493204     DOI: 10.1159/000091658

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  14 in total

1.  Characteristics of Children and Adolescents With Multiple Sclerosis.

Authors:  Anita L Belman; Lauren B Krupp; Cody S Olsen; John W Rose; Greg Aaen; Leslie Benson; Tanuja Chitnis; Mark Gorman; Jennifer Graves; Yolander Harris; Tim Lotze; Jayne Ness; Moses Rodriguez; Jan-Mendelt Tillema; Emmanuelle Waubant; Bianca Weinstock-Guttman; T Charles Casper
Journal:  Pediatrics       Date:  2016-07       Impact factor: 7.124

Review 2.  Pediatric multiple sclerosis.

Authors:  E Ann Yeh; Tanuja Chitnis; Lauren Krupp; Jayne Ness; Dorothée Chabas; Nancy Kuntz; Emmanuelle Waubant
Journal:  Nat Rev Neurol       Date:  2009-10-13       Impact factor: 42.937

3.  Pediatric multiple sclerosis.

Authors:  Yashma Patel; Vikram Bhise; Lauren Krupp
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

4.  The association between multiple sclerosis and fracture risk.

Authors:  Shile Su; Hao Liu
Journal:  Int J Clin Exp Med       Date:  2014-11-15

5.  Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children.

Authors:  A Langer-Gould; J L Zhang; J Chung; Y Yeung; E Waubant; J Yao
Journal:  Neurology       Date:  2011-08-24       Impact factor: 9.910

6.  Cyclophosphamide therapy in pediatric multiple sclerosis.

Authors:  N Makhani; M P Gorman; H M Branson; L Stazzone; B L Banwell; T Chitnis
Journal:  Neurology       Date:  2009-05-13       Impact factor: 9.910

7.  Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis.

Authors:  Katherine A McLaughlin; Tanuja Chitnis; Jia Newcombe; Bettina Franz; Julia Kennedy; Shannon McArdel; Jens Kuhle; Ludwig Kappos; Kevin Rostasy; Daniela Pohl; Donald Gagne; Jayne M Ness; Silvia Tenembaum; Kevin C O'Connor; Vissia Viglietta; Susan J Wong; Norma P Tavakoli; Jerome de Seze; Zhannat Idrissova; Samia J Khoury; Amit Bar-Or; David A Hafler; Brenda Banwell; Kai W Wucherpfennig
Journal:  J Immunol       Date:  2009-08-17       Impact factor: 5.422

8.  Incidence of acquired demyelinating syndromes of the CNS in Dutch children: a nationwide study.

Authors:  I A Ketelslegers; C E Catsman-Berrevoets; R F Neuteboom; M Boon; K G J van Dijk; M J Eikelenboom; R H J M Gooskens; E H Niks; W C G Overweg-Plandsoen; E A J Peeters; C M P C D Peeters-Scholte; B T Poll-The; J F de Rijk-van Andel; J P A Samijn; I N Snoeck; H Stroink; R J Vermeulen; A Verrips; J S H Vles; M A A P Willemsen; R Rodrigues Pereira; R Q Hintzen
Journal:  J Neurol       Date:  2012-02-17       Impact factor: 4.849

Review 9.  Management of multiple sclerosis in adolescents - current treatment options and related adherence issues.

Authors:  Jean K Mah; Jennifer E Thannhauser
Journal:  Adolesc Health Med Ther       Date:  2010-06-17

Review 10.  Pediatric multiple sclerosis: current concepts and consensus definitions.

Authors:  Joaquin A Pena; Timothy E Lotze
Journal:  Autoimmune Dis       Date:  2013-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.